PubMed

Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.

Podlekareva DN, Mocroft A, Post FA, Riekstina V, Miro JM, Furrer H, Bruyand M, Panteleev AM, Rakhmanova AG, Girardi E, Losso MH, Toibaro JJ, Caylá J, Miller RF, Obel N, Skrahina A, Chentsova N, Lundgren JD, Kirk O; HIV/TB Study Writing Group.

AIDS. 2009 Nov 27;23(18):2485-95.PMID: 19898216 [PubMed - in process]Related articles

Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.

Kowalska J, Kirk O, Mocroft A, Høj L, Friis-Møller N, Reiss P, Weller I, Lundgren J.

HIV Med. 2009 Oct 27. [Epub ahead of print]PMID: 19863618 [PubMed - as supplied by publisher]Related articles

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

antiretroviral therapy cohort collaboration (ART-CC), Lanoy E, May M, Mocroft A, Phillip A, Justice A, Chêne G, Furrer H, Sterling T, Monforte AD, Force L, Gill J, Harris R, Hogg RS, Rockstroh J, Saag M, Khaykin P, de Wolf F, Sterne JA, Costagliola D.

AIDS. 2009 Oct 23;23(16):2199-208.PMID: 19779320 [PubMed - in process]Related articles

Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.

Moore DM, Harris R, Lima V, Hogg B, May M, Yip B, Justice A, Mocroft A, Reiss P, Lampe F, Chêne G, Costagliola D, Elzi L, Mugavero MJ, Monforte AD, Sabin C, Podzamczer D, Fätkenheuer G, Staszewski S, Gill J, Sterne JA; Antiretroviral Therapy Cohort Collaboration.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):357-63.PMID: 19668084 [PubMed - indexed for MEDLINE]Related articles

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine Toxicity Multicohort Collaboration.

AIDS. 2009 Aug 24;23(13):1689-99.PMID: 19487907 [PubMed - in process]Related articles

Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.

Peters L, Mocroft A, Soriano V, Rockstroh JK, Losso M, Valerio L, Aldins P, Reiss P, Ledergerber B, Lundgren JD; EuroSIDA Study Group.

J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):457-63.PMID: 19360931 [PubMed - indexed for MEDLINE]Related articles

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.

van Luin M, Bannister WP, Mocroft A, Reiss P, Di Perri G, Peytavin G, Molto J, Karlson A, Castagna A, Beniowski M, Lundgren JD, Burger DM; EuroSIDA Study Group.

Antivir Ther. 2009;14(1):75-83.PMID: 19320239 [PubMed - indexed for MEDLINE]Related articles

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.

Antiretroviral Therapy Cohort Collaboration (ART-CC), Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H, Sabin C, Fatkenheuer G, Justice A, Reiss P, d'Arminio Monforte A, Gill J, Hogg R, Bonnet F, Kitahata M, Staszewski S, Casabona J, Harris R, Saag M.

Clin Infect Dis. 2009 Apr 15;48(8):1138-51.PMID: 19275498 [PubMed - indexed for MEDLINE]Related articles

Use of risk equations for predicting disease progression in HIV infection.

Mocroft A, Lundgren JD.

Clin Infect Dis. 2009 Apr 1;48(7):951-3. No abstract available. PMID: 19226232 [PubMed - indexed for MEDLINE]Related articles

Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.

Harris RJ, Sterne JA, Abgrall S, Dabis F, Reiss P, Saag M, Phillips AN, Chêne G, Gill JM, Justice AC, Rockstroh J, Sabin CA, Mocroft A, Bucher HC, Hogg RS, Monforte AD, May M, Egger M; Antiretroviral Therapy Cohort Collaboration.

Antivir Ther. 2008;13(8):959-67.PMID: 19195321 [PubMed - indexed for MEDLINE]Related articles

Interruption of antiretroviral therapy is associated with increased plasma cystatin C.

Mocroft A, Wyatt C, Szczech L, Neuhaus J, El-Sadr W, Tracy R, Kuller L, Shlipak M, Angus B, Klinker H, Ross M; INSIGHT SMART Study Group.

AIDS. 2009 Jan 2;23(1):71-82.PMID: 19050388 [PubMed - indexed for MEDLINE]Related articles

Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

Reekie J, Mocroft A, Sambatakou H, Machala L, Chiesi A, van Lunzen J, Clumeck N, Kirk O, Gazzard B, Lundgren JD; EuroSIDA Study Group.

AIDS. 2008 Nov 12;22(17):2381-90.PMID: 18981778 [PubMed - indexed for MEDLINE]Related articles

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.

Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD; SMART Study Group and International Network for Strategic Initiatives in Global HIV Trials (INSIGHT).

Clin Infect Dis. 2008 Dec 1;47(11):1468-75.PMID: 18959492 [PubMed - indexed for MEDLINE]Related articles

The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.

Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, Kirk O; EuroSIDA Study Group.

Cent Eur J Public Health. 2008 Sep;16(3):99-105. Review.PMID: 18935770 [PubMed - indexed for MEDLINE]Related articles

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.

Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group.

AIDS. 2008 Oct 18;22(16):2187-98.PMID: 18832882 [PubMed - indexed for MEDLINE]Related articles

Incidence of abacavir hypersensitivity reactions in euroSIDA.

Bannister WP, Friis-Møller N, Mocroft A, Viard JP, van Lunzen J, Kirk O, Gargalianos P, Bánhegyi D, Chiesi A, Lundgren JD; EuroSIDA Study Group.

Antivir Ther. 2008;13(5):687-96.PMID: 18771052 [PubMed - indexed for MEDLINE]Related articles

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2008 Nov 1;198(9):1337-44.PMID: 18767985 [PubMed - indexed for MEDLINE]Related articles

Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.

Podlekareva D, Mocroft A, Kirk O, Reiss P, Aldins P, Katlama C, Kovari H, Stellbrink HJ, D'Arminio Monforte A, Lundgren JD; Eurosida Study Group.

Scand J Infect Dis. 2008;40(11-12):908-13.PMID: 18609197 [PubMed - indexed for MEDLINE]Related articles

Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.

Bannister WP, Cozzi-Lepri A, Clotet B, Mocroft A, Kjaer J, Reiss P, von Wyl V, Lazzarin A, Katlama C, Phillips AN, Ruiz L, Lundgren JD; EuroSIDA study group.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):324-33.PMID: 18545152 [PubMed - indexed for MEDLINE]Related articles

Analysis of the incidence and mortality of vulval cancer in women in South East England 1960-1999.

Somoye GO, Mocroft A, Olaitan A.

Arch Gynecol Obstet. 2009 Feb;279(2):113-7. Epub 2008 May 17.PMID: 18488239 [PubMed - indexed for MEDLINE]Related articles

Incidence of pancreatitis in HIV-infected patients, and the association with antiretroviral therapy.

Smith CJ, Mocroft A, Lundgren JD; EuroSIDA Study Group.

AIDS. 2008 May 11;22(8):997-8. No abstract available. PMID: 18453864 [PubMed - indexed for MEDLINE]Related articles

Loss to follow-up in an international, multicentre observational study.

Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, Vetter N, Dabis F, Gatell J, Lundgren JD; EuroSIDA study group.

HIV Med. 2008 May;9(5):261-9.PMID: 18400074 [PubMed - indexed for MEDLINE]Related articles

Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999.

Mocroft A, Horban A, Clotet B, d'Arminio Monforte A, Bogner JR, Aldins P, Staub T, Antunes F, Katlama C, Lundgren JD; EuroSIDA Study Group.

HIV Med. 2008 Jan;9(1):41-6.PMID: 18199171 [PubMed - indexed for MEDLINE]Related articles

Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.

Bannister WP, Ruiz L, Cozzi-Lepri A, Mocroft A, Kirk O, Staszewski S, Loveday C, Karlsson A, Monforte A, Clotet B, Lundgren JD; EuroSIDA study group.

AIDS. 2008 Jan 30;22(3):367-76.PMID: 18195563 [PubMed - indexed for MEDLINE]Related articles

The role of antiretroviral therapy in the incidence of pancreatitis in HIV-positive individuals in the EuroSIDA study.

Smith CJ, Olsen CH, Mocroft A, Viard JP, Staszewski S, Panos G, Staub T, Blaxhult A, Vetter N, Lundgren JD.

AIDS. 2008 Jan 2;22(1):47-56.PMID: 18090391 [PubMed - indexed for MEDLINE]Related articles

Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.

Antiretroviral Therapy in Low-Income Countries Collaboration of the International epidemiological Databases to Evaluate AIDS (IeDEA); ART Cohort Collaboration, Brinkhof MW, Egger M, Boulle A, May M, Hosseinipour M, Sprinz E, Braitstein P, Dabis F, Reiss P, Bangsberg DR, Rickenbach M, Miro JM, Myer L, Mocroft A, Nash D, Keiser O, Pascoe M, van der Borght S, Schechter M.

Clin Infect Dis. 2007 Dec 1;45(11):1518-21. Epub 2007 Oct 22.PMID: 17990236 [PubMed - indexed for MEDLINE]Related articles

Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection.

Kowalska JD, Mocroft A, Blaxhult A, Colebunders R, van Lunzen J, Podlekareva D, Hansen AB, Machala L, Yust I, Benfield T; for the EuroSIDA Study Group.

AIDS Res Hum Retroviruses. 2007 Oct;23(10):1183-8.PMID: 17961102 [PubMed - indexed for MEDLINE]Related articles

Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients.

Ceccherini-Silberstein F, Cozzi-Lepri A, Ruiz L, Mocroft A, Phillips AN, Olsen CH, Gatell JM, Gunthard HF, Reiss P, Perno CF, Clotet B, Lundgren JD; EuroSIDA Study Group.

J Infect Dis. 2007 Oct 15;196(8):1180-90. Epub 2007 Sep 19.PMID: 17955437 [PubMed - indexed for MEDLINE]Related articles

Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.

Mocroft A, Ledergerber B, Zilmer K, Kirk O, Hirschel B, Viard JP, Reiss P, Francioli P, Lazzarin A, Machala L, Phillips AN, Lundgren JD; EuroSIDA study group and the Swiss HIV Cohort Study.

AIDS. 2007 Sep 12;21(14):1867-75.PMID: 17721094 [PubMed - indexed for MEDLINE]Related articles

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.

Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, Clumeck N, Losso M, Lazzarin A, Fatkenheuer G, Lundgren JD; EuroSIDA study group.

Lancet. 2007 Aug 4;370(9585):407-13.PMID: 17659333 [PubMed - indexed for MEDLINE]Related articles

Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.

Mocroft A, Staszewski S, Weber R, Gatell J, Rockstroh J, Gasiorowski J, Panos G, Monforte A, Rakhmanova A, Phillips AN, Lundgren JD; EuroSIDA study group.

Antivir Ther. 2007;12(3):325-33. Erratum in: Antivir Ther. 2007;12(4):577. PMID: 17591022 [PubMed - indexed for MEDLINE]Related articles

Chronic renal failure among HIV-1-infected patients.

Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD.

AIDS. 2007 May 31;21(9):1119-27.PMID: 17502722 [PubMed - indexed for MEDLINE]Related articles

Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.

Holkmann Olsen C, Mocroft A, Kirk O, Vella S, Blaxhult A, Clumeck N, Fisher M, Katlama C, Phillips AN, Lundgren JD; EuroSIDA study group.

HIV Med. 2007 Mar;8(2):96-104.PMID: 17352766 [PubMed - indexed for MEDLINE]Related articles

HIV-1 subtypes and response to combination antiretroviral therapy in Europe.

Bannister WP, Ruiz L, Loveday C, Vella S, Zilmer K, Kjaer J, Knysz B, Phillips AN, Mocroft A; EuroSIDA Study Group.

Antivir Ther. 2006;11(6):707-15.PMID: 17310815 [PubMed - indexed for MEDLINE]Related articles

Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C.

Mocroft A, Rockstroh J, Soriano V, Kirk O, Viard JP, Caplinskas S, Gasiorowski J, Chiesi A, Phillips AN, Lundgren JD, EuroSIDA Study Group.

Scand J Infect Dis. 2006;38(11-12):1092-7.PMID: 17148084 [PubMed - indexed for MEDLINE]Related articles

The impact of antiretroviral therapy on AIDS and survival.

Lundgren JD, Mocroft A.

J HIV Ther. 2006 Jun;11(2):36-8. Review. No abstract available. PMID: 16981594 [PubMed - indexed for MEDLINE]Related articles

Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.

Podlekareva D, Mocroft A, Dragsted UB, Ledergerber B, Beniowski M, Lazzarin A, Weber J, Clumeck N, Vetter N, Phillips A, Lundgren JD; EuroSIDA study group.

J Infect Dis. 2006 Sep 1;194(5):633-41. Epub 2006 Jul 24.PMID: 16897662 [PubMed - indexed for MEDLINE]Related articles

The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era.

Mocroft A, Neaton J, Bebchuk J, Staszewski S, Antunes F, Knysz B, Law M, Phillips AN, Lundgren JD; EuroSIDA Study Group; ESPRIT Study Group.

Clin Trials. 2006;3(2):119-32.PMID: 16773954 [PubMed - indexed for MEDLINE]Related articles

Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe.

Bannister WP, Kirk O, Gatell JM, Knysz B, Viard JP, Mens H, Monforte AD, Phillips AN, Mocroft A, Lundgren JD; EuroSIDA Study Group.

J Acquir Immune Defic Syndr. 2006 Jun;42(2):229-37.PMID: 16760800 [PubMed - indexed for MEDLINE]Related articles

Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.

Mocroft A, Phillips AN, Ledergerber B, Katlama C, Chiesi A, Goebel FD, Knysz B, Antunes F, Reiss P, Lundgren JD.

AIDS. 2006 May 12;20(8):1141-50.PMID: 16691065 [PubMed - indexed for MEDLINE]Related articles

Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

Mocroft A, Rockstroh J, Soriano V, Ledergerber B, Kirk O, Vinogradova E, Reiss P, Katlama C, Phillips AN, Lundgren JD; EuroSIDA Study Group.

Antivir Ther. 2005;10(7):779-90.PMID: 16312175 [PubMed - indexed for MEDLINE]Related articles

Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, de Wit S, Gatell J, Clotet B, Phillips AN, Lundgren JD; EuroSIDA Study Group.

AIDS. 2005 Dec 2;19(18):2117-25.PMID: 16284461 [PubMed - indexed for MEDLINE]Related articles

Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection.

Mocroft A, Phillips AN, Soriano V, Rockstroh J, Blaxhult A, Katlama C, Boron-Kaczmarska A, Viksna L, Kirk O, Lundgren JD; EuroSIDA Study Group.

AIDS Res Hum Retroviruses. 2005 Sep;21(9):743-52.PMID: 16218797 [PubMed - indexed for MEDLINE]Related articles

Age related trends in the incidence of endometrial cancer in South East England 1962-1997.

Somoye G, Olaitan A, Mocroft A, Jacobs I.

J Obstet Gynaecol. 2005 Jan;25(1):35-8.PMID: 16147691 [PubMed - indexed for MEDLINE]Related articles

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2005 Sep 15;192(6):992-1002. Epub 2005 Aug 11.PMID: 16107951 [PubMed - indexed for MEDLINE]Related articles

Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection.

Mocroft A, Phillips AN, Soriano V, Rockstroh J, Blaxhult A, Katlama C, Boron-Kaczmarska A, Viksna L, Kirk O, Lundgren JD; EuroSIDA Study Group.

AIDS Res Hum Retroviruses. 2005 Jun;21(6):527-36.PMID: 15989457 [PubMed - indexed for MEDLINE]Related articles

Decline in esophageal candidiasis and use of antimycotics in European patients with HIV.

Mocroft A, Oancea C, van Lunzen J, Vanhems P, Banhegyi D, Chiesi A, Vinogradova E, Maayan S, Phillips AN, Lundgren J; EuroSIDA study group.

Am J Gastroenterol. 2005 Jul;100(7):1446-54.PMID: 15984964 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.

Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD; EuroSIDA Group.

AIDS. 2005 Mar 24;19(6):593-601.PMID: 15802978 [PubMed - indexed for MEDLINE]Related articles

Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy.

Mocroft A, Gatell J, Reiss P, Ledergerber B, Kirk O, Vella S, Blaxhult A, Phillips AN, Lundgren J; EuroSIDA study group.

AIDS. 2004 Nov 19;18(17):2333-7.PMID: 15577550 [PubMed - indexed for MEDLINE]Related articles

Application of multiplex ligation-dependent probe analysis to define a small deletion encompassing PMP22 exons 4 and 5 in hereditary neuropathy with liability to pressure palsies.

Sutton IJ, Mocroft AP, Lindley VH, Barber RM, Bryon RJ, Winer JB, MacDonald F.

Neuromuscul Disord. 2004 Dec;14(12):804-9.PMID: 15564036 [PubMed - indexed for MEDLINE]Related articles